Skip to main content
Top
Published in: Diabetology & Metabolic Syndrome 1/2017

Open Access 01-12-2017 | Research

Low serum adiponectin level is associated with metabolic syndrome and is an independent marker of peripheral arterial stiffness in hypertensive patients

Authors: Ming-Chun Chen, Chung-Jen Lee, Chiu-Fen Yang, Yu-Chih Chen, Ji-Hung Wang, Bang-Gee Hsu

Published in: Diabetology & Metabolic Syndrome | Issue 1/2017

Login to get access

Abstract

Background

Adiponectin has been implicated in metabolic syndrome (MetS) and arterial stiffness (AS). We aim to determine the relationship between serum adiponectin concentration as well as peripheral AS in hypertensive patients.

Methods

Fasting blood samples were obtained from 101 hypertensive patients. Brachial-ankle pulse wave velocity (baPWV) was measured with an automatic pulse wave analyzer. Serum adiponectin concentrations were determined by using an enzyme immunoassay kit. A baPWV >14.0 m/s was defined as high AS.

Results

MetS and high AS were present in 62.4 and 71.3% of the study population. Adiponectin was inversely associated with MetS and high AS (both P < 0.001). Serum higher high-density lipoprotein cholesterol (HDL-C) (P = 0.012), triglycerides (P = 0.001), C-reactive protein (P < 0.001), insulin (P = 0.027), body weight (P = 0.002), waist circumference (WC, P < 0.001), body mass index (P = 0.001) bilateral-baPWV (P < 0.001), systolic blood pressure (SBP, P < 0.001), diastolic blood pressure (DBP, P = 0.012), pulse pressure (P = 0.019), homeostasis model assessment of insulin resistance (HOMA1-IR (P = 0.026) and HOMA2-IR (P = 0.020)) and lower glomerular filtration rate (GFR, P = 0.029) were significantly associated with high AS. Multivariate logistic regression analysis of the factors significantly associated with AS revealed that adiponectin [odds ratio: 0.932, 95% confidence interval (CI) 0.881–0.985, P = 0.012], and SBP (odds ratio: 1.059, 95% CI 1.008–1.113, P = 0.022) were the independent predictors of arterial stiffness in hypertensive patients. Subgroup analysis revealed that SBP (odds ratio: 1.126, 95% CI 1.024–1.237, P = 0.014) and GFR (odds ratio: 0.858, 95% CI 0.739–0.996, P = 0.043) were the independent predictors of arterial stiffness in hypertensive patients without MetS; adiponectin (odds ratio: 0.909, 95% CI 0.931–0.996, P = 0.040) was the independent predictor of arterial stiffness in hypertensive patients with MetS.

Conclusions

Hypoadiponectinemia has positive association with MetS and peripheral AS in hypertensive patients.
Appendix
Available only for authorised users
Literature
1.
go back to reference Vlachopoulos C, Xaplanteris P, Aboyans V, et al. The role of vascular biomarkers for primary and secondary prevention. A position paper from the european society of cardiology working group on peripheral circulation: endorsed by the association for research into arterial structure and physiology (artery) society. Atherosclerosis. 2015;241:507–32.CrossRefPubMed Vlachopoulos C, Xaplanteris P, Aboyans V, et al. The role of vascular biomarkers for primary and secondary prevention. A position paper from the european society of cardiology working group on peripheral circulation: endorsed by the association for research into arterial structure and physiology (artery) society. Atherosclerosis. 2015;241:507–32.CrossRefPubMed
2.
go back to reference Chen MC, Hsu BG, Lee CJ, et al. Hyperleptinaemia positively correlates with cardiometabolic syndrome in hypertensive patients. Int J Clin Exp Pathol. 2016;9:12959–67. Chen MC, Hsu BG, Lee CJ, et al. Hyperleptinaemia positively correlates with cardiometabolic syndrome in hypertensive patients. Int J Clin Exp Pathol. 2016;9:12959–67.
3.
go back to reference Chang LC, Huang KC, Wu YW, et al. The clinical implications of blood adiponectin in cardiometabolic disorders. J Formos Med Assoc. 2009;108:353–66.CrossRefPubMed Chang LC, Huang KC, Wu YW, et al. The clinical implications of blood adiponectin in cardiometabolic disorders. J Formos Med Assoc. 2009;108:353–66.CrossRefPubMed
4.
go back to reference Lindberg S, Jensen JS, Bjerre M, et al. Low adiponectin levels at baseline and decreasing adiponectin levels over 10 years of follow-up predict risk of the metabolic syndrome. Diabetes Metab. 2017;43:134-9.CrossRefPubMed Lindberg S, Jensen JS, Bjerre M, et al. Low adiponectin levels at baseline and decreasing adiponectin levels over 10 years of follow-up predict risk of the metabolic syndrome. Diabetes Metab. 2017;43:134-9.CrossRefPubMed
5.
go back to reference Yamauchi T, Kadowaki T. Physiological and pathophysiological roles of adiponectin and adiponectin receptors in the integrated regulation of metabolic and cardiovascular diseases. Int J Obes. 2008;32(Suppl 7):S13–8.CrossRef Yamauchi T, Kadowaki T. Physiological and pathophysiological roles of adiponectin and adiponectin receptors in the integrated regulation of metabolic and cardiovascular diseases. Int J Obes. 2008;32(Suppl 7):S13–8.CrossRef
6.
go back to reference Hsu BG, Liou HH, Lee CJ, et al. Serum sclerostin as an independent marker of peripheral arterial stiffness in renal transplantation recipients: a cross-sectional study. Medicine. 2016;95:e3300.CrossRefPubMedPubMedCentral Hsu BG, Liou HH, Lee CJ, et al. Serum sclerostin as an independent marker of peripheral arterial stiffness in renal transplantation recipients: a cross-sectional study. Medicine. 2016;95:e3300.CrossRefPubMedPubMedCentral
7.
go back to reference Yamashina A, Tomiyama H, Arai T, et al. Brachial-ankle pulse wave velocity as a marker of atherosclerotic vascular damage and cardiovascular risk. Hypertens Res. 2003;26:615–22.CrossRefPubMed Yamashina A, Tomiyama H, Arai T, et al. Brachial-ankle pulse wave velocity as a marker of atherosclerotic vascular damage and cardiovascular risk. Hypertens Res. 2003;26:615–22.CrossRefPubMed
8.
go back to reference Yokoyama H, Hirasawa K, Aoki T, et al. Brachial-ankle pulse wave velocity measured automatically by oscillometric method is elevated in diabetic patients with incipient nephropathy. Diabet Med. 2003;20:942–5.CrossRefPubMed Yokoyama H, Hirasawa K, Aoki T, et al. Brachial-ankle pulse wave velocity measured automatically by oscillometric method is elevated in diabetic patients with incipient nephropathy. Diabet Med. 2003;20:942–5.CrossRefPubMed
9.
go back to reference Wang JM, Su C, Wang Y, et al. Elevated circulating endothelial microparticles and brachial-ankle pulse wave velocity in well-controlled hypertensive patients. J Hum Hypertens. 2009;23:307–15.CrossRefPubMed Wang JM, Su C, Wang Y, et al. Elevated circulating endothelial microparticles and brachial-ankle pulse wave velocity in well-controlled hypertensive patients. J Hum Hypertens. 2009;23:307–15.CrossRefPubMed
10.
go back to reference Vlachopoulos C, Aznaouridis K, Terentes-Printzios D, et al. Prediction of cardiovascular events and all-cause mortality with brachial-ankle elasticity index: a systematic review and meta-analysis. Hypertension. 2012;60:556–62.CrossRefPubMed Vlachopoulos C, Aznaouridis K, Terentes-Printzios D, et al. Prediction of cardiovascular events and all-cause mortality with brachial-ankle elasticity index: a systematic review and meta-analysis. Hypertension. 2012;60:556–62.CrossRefPubMed
11.
12.
go back to reference Tsioufis C, Dimitriadis K, Selima M, et al. Low-grade inflammation and hypoadiponectinaemia have an additive detrimental effect on aortic stiffness in essential hypertensive patients. Eur Heart J. 2007;28:1162–9.CrossRefPubMed Tsioufis C, Dimitriadis K, Selima M, et al. Low-grade inflammation and hypoadiponectinaemia have an additive detrimental effect on aortic stiffness in essential hypertensive patients. Eur Heart J. 2007;28:1162–9.CrossRefPubMed
13.
go back to reference Ho GJ, Lee MC, Lee CJ, et al. Hypoadiponectinemia correlates with arterial stiffness in kidney transplantation patients. Clin Exp Nephrol. 2015;19:534–41.CrossRefPubMed Ho GJ, Lee MC, Lee CJ, et al. Hypoadiponectinemia correlates with arterial stiffness in kidney transplantation patients. Clin Exp Nephrol. 2015;19:534–41.CrossRefPubMed
14.
go back to reference Hsu BG, Shih MH, Chen YC, et al. High Serum osteoprotegerin is associated with arterial stiffness in kidney transplant patients. Tohoku J Exp Med. 2015;236:247–53.CrossRefPubMed Hsu BG, Shih MH, Chen YC, et al. High Serum osteoprotegerin is associated with arterial stiffness in kidney transplant patients. Tohoku J Exp Med. 2015;236:247–53.CrossRefPubMed
15.
go back to reference Alberti KG, Zimmet P, Shaw J. Metabolic syndrome—a new world-wide definition. a consensus statement from the international diabetes federation. Diabet Med. 2006;23:469–80.CrossRefPubMed Alberti KG, Zimmet P, Shaw J. Metabolic syndrome—a new world-wide definition. a consensus statement from the international diabetes federation. Diabet Med. 2006;23:469–80.CrossRefPubMed
16.
go back to reference Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998;15:539–53.CrossRefPubMed Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998;15:539–53.CrossRefPubMed
17.
go back to reference Wang JH, Lee CJ, Hsieh JC, et al. Inverse association of long-acting natriuretic peptide with metabolic syndrome in congestive heart failure patients. Diabetol Metab Syndr. 2013;5:19.CrossRefPubMedPubMedCentral Wang JH, Lee CJ, Hsieh JC, et al. Inverse association of long-acting natriuretic peptide with metabolic syndrome in congestive heart failure patients. Diabetol Metab Syndr. 2013;5:19.CrossRefPubMedPubMedCentral
18.
go back to reference Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care. 2004;27:1487–95.CrossRefPubMed Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care. 2004;27:1487–95.CrossRefPubMed
19.
go back to reference Cantley J. The control of insulin secretion by adipokines: current evidence for adipocyte-beta cell endocrine signaling in metabolic homeostasis. Mamm Genome. 2014;25:442–54.CrossRefPubMed Cantley J. The control of insulin secretion by adipokines: current evidence for adipocyte-beta cell endocrine signaling in metabolic homeostasis. Mamm Genome. 2014;25:442–54.CrossRefPubMed
20.
go back to reference Ziemke F, Mantzoros CS. Adiponectin in insulin resistance: lessons from translational research. Am J Clin Nutr. 2010;91:258s–61s.CrossRefPubMed Ziemke F, Mantzoros CS. Adiponectin in insulin resistance: lessons from translational research. Am J Clin Nutr. 2010;91:258s–61s.CrossRefPubMed
21.
go back to reference Nakashima R, Yamane K, Kamei N, et al. Low serum levels of total and high-molecular-weight adiponectin predict the development of metabolic syndrome in Japanese-Americans. J Endocrinol Invest. 2011;34:615–9.PubMed Nakashima R, Yamane K, Kamei N, et al. Low serum levels of total and high-molecular-weight adiponectin predict the development of metabolic syndrome in Japanese-Americans. J Endocrinol Invest. 2011;34:615–9.PubMed
22.
go back to reference Saisho Y, Hirose H, Roberts R, et al. C-reactive protein, high-molecular-weight adiponectin and development of metabolic syndrome in the japanese general population: a longitudinal cohort study. PLoS ONE. 2013;8:e73430.CrossRefPubMedPubMedCentral Saisho Y, Hirose H, Roberts R, et al. C-reactive protein, high-molecular-weight adiponectin and development of metabolic syndrome in the japanese general population: a longitudinal cohort study. PLoS ONE. 2013;8:e73430.CrossRefPubMedPubMedCentral
23.
go back to reference Kim JY, Ahn SV, Yoon JH, et al. Prospective study of serum adiponectin and incident metabolic syndrome: the arirang study. Diabetes Care. 2013;36:1547–53.CrossRefPubMedPubMedCentral Kim JY, Ahn SV, Yoon JH, et al. Prospective study of serum adiponectin and incident metabolic syndrome: the arirang study. Diabetes Care. 2013;36:1547–53.CrossRefPubMedPubMedCentral
24.
go back to reference Kawamoto R, Tabara Y, Kohara K, et al. Serum high molecular weight adiponectin correlates with arterial stiffness in community-dwelling persons. Endocr Res. 2011;36:53–63.CrossRefPubMed Kawamoto R, Tabara Y, Kohara K, et al. Serum high molecular weight adiponectin correlates with arterial stiffness in community-dwelling persons. Endocr Res. 2011;36:53–63.CrossRefPubMed
25.
go back to reference Li CI, Kardia SL, Liu CS, et al. Metabolic syndrome is associated with change in subclinical arterial stiffness: a community-based taichung community health study. BMC Public Health. 2011;11:808.CrossRefPubMedPubMedCentral Li CI, Kardia SL, Liu CS, et al. Metabolic syndrome is associated with change in subclinical arterial stiffness: a community-based taichung community health study. BMC Public Health. 2011;11:808.CrossRefPubMedPubMedCentral
26.
go back to reference Li B, Gao H, Li X, et al. Correlation between brachial-ankle pulse wave velocity and arterial compliance and cardiovascular risk factors in elderly patients with arteriosclerosis. Hypertens Res. 2006;29:309–14.CrossRefPubMed Li B, Gao H, Li X, et al. Correlation between brachial-ankle pulse wave velocity and arterial compliance and cardiovascular risk factors in elderly patients with arteriosclerosis. Hypertens Res. 2006;29:309–14.CrossRefPubMed
27.
go back to reference Kawamoto R, Kohara K, Tabara Y, et al. An association between decreased estimated glomerular filtration rate and arterial stiffness. Intern Med. 2008;47:593–8.CrossRefPubMed Kawamoto R, Kohara K, Tabara Y, et al. An association between decreased estimated glomerular filtration rate and arterial stiffness. Intern Med. 2008;47:593–8.CrossRefPubMed
28.
go back to reference Miyai N, Arita M, Miyashita K, et al. The influence of obesity and metabolic risk variables on brachial-ankle pulse wave velocity in healthy adolescents. J Hum Hypertens. 2009;23:444–50.CrossRefPubMed Miyai N, Arita M, Miyashita K, et al. The influence of obesity and metabolic risk variables on brachial-ankle pulse wave velocity in healthy adolescents. J Hum Hypertens. 2009;23:444–50.CrossRefPubMed
30.
go back to reference Tsai JP, Hsu BG, Lee CJ, et al. Serum leptin is a predictor for central arterial stiffness in hypertensive patients. Nephrology. 2017. doi:10.1111/nep.12859. Tsai JP, Hsu BG, Lee CJ, et al. Serum leptin is a predictor for central arterial stiffness in hypertensive patients. Nephrology. 2017. doi:10.​1111/​nep.​12859.
31.
go back to reference Tan J, Hua Q, Xing X, et al. Impact of the metalloproteinase-9/tissue inhibitor of metalloproteinase-1 system on large arterial stiffness in patients with essential hypertension. Hypertens Res. 2007;30:959–63.CrossRefPubMed Tan J, Hua Q, Xing X, et al. Impact of the metalloproteinase-9/tissue inhibitor of metalloproteinase-1 system on large arterial stiffness in patients with essential hypertension. Hypertens Res. 2007;30:959–63.CrossRefPubMed
32.
go back to reference Sung SH, Chuang SY, Sheu WH, et al. Relation of adiponectin and high-sensitivity c-reactive protein to pulse-wave velocity and n-terminal pro-b-type natriuretic peptide in the general population. Am J Cardiol. 2009;103:1411–6.CrossRefPubMed Sung SH, Chuang SY, Sheu WH, et al. Relation of adiponectin and high-sensitivity c-reactive protein to pulse-wave velocity and n-terminal pro-b-type natriuretic peptide in the general population. Am J Cardiol. 2009;103:1411–6.CrossRefPubMed
33.
go back to reference Plant S, Shand B, Elder P, et al. Adiponectin attenuates endothelial dysfunction induced by oxidised low-density lipoproteins. Diab Vasc Dis Res. 2008;5:102–8.CrossRefPubMed Plant S, Shand B, Elder P, et al. Adiponectin attenuates endothelial dysfunction induced by oxidised low-density lipoproteins. Diab Vasc Dis Res. 2008;5:102–8.CrossRefPubMed
34.
go back to reference Chen L, Zhu W, Mai L, et al. The association of metabolic syndrome and its components with brachial-ankle pulse wave velocity in South China. Atherosclerosis. 2015;240:345–50.CrossRefPubMed Chen L, Zhu W, Mai L, et al. The association of metabolic syndrome and its components with brachial-ankle pulse wave velocity in South China. Atherosclerosis. 2015;240:345–50.CrossRefPubMed
35.
go back to reference Saito I, Yamagishi K, Chei CL, et al. Total and high molecular weight adiponectin levels and risk of cardiovascular disease in individuals with high blood glucose levels. Atherosclerosis. 2013;229:222–7.CrossRefPubMed Saito I, Yamagishi K, Chei CL, et al. Total and high molecular weight adiponectin levels and risk of cardiovascular disease in individuals with high blood glucose levels. Atherosclerosis. 2013;229:222–7.CrossRefPubMed
36.
go back to reference Park HJ, Rho TH, Park CS, et al. The relationship between the acute changes of the systolic blood pressure and the brachial-ankle pulse wave velocity. Korean J Intern Med. 2007;22:147–51.CrossRefPubMedPubMedCentral Park HJ, Rho TH, Park CS, et al. The relationship between the acute changes of the systolic blood pressure and the brachial-ankle pulse wave velocity. Korean J Intern Med. 2007;22:147–51.CrossRefPubMedPubMedCentral
Metadata
Title
Low serum adiponectin level is associated with metabolic syndrome and is an independent marker of peripheral arterial stiffness in hypertensive patients
Authors
Ming-Chun Chen
Chung-Jen Lee
Chiu-Fen Yang
Yu-Chih Chen
Ji-Hung Wang
Bang-Gee Hsu
Publication date
01-12-2017
Publisher
BioMed Central
Published in
Diabetology & Metabolic Syndrome / Issue 1/2017
Electronic ISSN: 1758-5996
DOI
https://doi.org/10.1186/s13098-017-0247-8

Other articles of this Issue 1/2017

Diabetology & Metabolic Syndrome 1/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.